Genelux Enterprise Value Over E B I T D A from 2010 to 2024
Genelux Common Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA will likely drop to -13.31 in 2024. During the period from 2010 to 2024, Genelux Common Enterprise Value Over EBITDA regression line of annual values had significance of 0.34 and arithmetic mean of (20.68). View All Fundamentals
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (12.68) | Current Value (13.31) | Quarterly Volatility 22.59926105 |
Check Genelux Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genelux Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 883.5 K, Interest Expense of 4.2 M or Other Operating Expenses of 16.8 M, as well as many indicators such as Price To Sales Ratio of 2.1 K, Dividend Yield of 0.0 or PTB Ratio of 18.45. Genelux financial statements analysis is a perfect complement when working with Genelux Common Valuation or Volatility modules.
Genelux | Enterprise Value Over E B I T D A |
Latest Genelux Common's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Genelux Common over the last few years. It is Genelux Common's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genelux Common's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Genelux Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (20.68) | |
| Coefficient Of Variation | (109.28) | |
| Mean Deviation | 10.87 | |
| Median | (15.66) | |
| Standard Deviation | 22.60 | |
| Sample Variance | 510.73 | |
| Range | 90.4665 | |
| R-Value | (0.27) | |
| Mean Square Error | 511.04 | |
| R-Squared | 0.07 | |
| Significance | 0.34 | |
| Slope | (1.35) | |
| Total Sum of Squares | 7,150 |
Genelux Enterprise Value Over E B I T D A History
About Genelux Common Financial Statements
Genelux Common investors use historical fundamental indicators, such as Genelux Common's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genelux Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (12.68) | (13.31) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Tools for Genelux Stock
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |